Continued
| Bangladesh | Georgia | |
|---|---|---|
| Setting | A multistaged prospective study done in all eligible subjects of the village Mollargaon in Sylhet | The Project emphasises two phases. The phase I comprises of screening of target population to determine patients with chronic renal injury, diabetes, hypertension, cardiovascular disease. Phase II: People eligible for the comprehensive management programme were screened. All patients have been admitted to the leading hospitals of main cities of all regions of Georgia |
| Number of centres | One temporary centre | Seven permanent centres |
| Timing | 8 months | |
| Inclusion criteria | Age >18 years. High-risk subjects identified among those with hypertension, diabetes, prior CKD or prior heart attack or stroke at first stage screening/interview | All patients who have been admitted to the leading hospitals of main cities of all regions of Georgia during last 10 years with the following reasons: ▸ Chronic pyelonephritis ▸ Chronic glomerulonephritis ▸ Nephrolithiasis/urolithiasis ▸ Kidney cystic disease ▸ Multicystic dysplastic kidney ▸ Congenital malformations with renal function impairment ▸ Hypertension ▸ Heart attack/stroke ▸ Chronic renal failure ▸ Diabetes mellitus ▸ Tubulo-interstitial nephritis |
| Exclusion criteria | Pregnancy and any acute illness | Patients without confirmed medical diagnoses (based on medical documentation) excluded |
| Measurements | Interview including demographic, socioeconomic, dietary and health-related questions; serum creatinine, fasting glucose, dipstick albuminuria | Patient interview includes demographic, socioeconomic, dietary and health-related questions; physical examination and fasting serum creatinine, fasting glucose, total cholesterol, dipstick urinalysis for proteinuria and urinary ACR (repeated if positive) |
| Clinic staff | Doctors, nurses, health workers, medical students, laboratory technicians | Physicians, nurses and students trained to take part in data collection of the project |
| Advertising/promotion | Local community leaders and health workers were first contacted, the study was explained and showed them the medical information pamphlet | The appropriate education material for patients as well as for medical staff elaborated for further spread and acknowledgement |
| Follow-up visits | No follow-up arranged | Patients are followed up twice in the first month of the treatment period, particularly to monitor potential ACE inhibitor complications. Follow-up assessment made every 6 months |
ACR, albumin creatinine ratio; CKD, chronic kidney disease NHANES, National Health and Nutrition Examination Survey.